Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

GSK eyes future growth with cost-cutting plan amid promising Q2

GSK will reallocate a large portion of capital saved from the £1.9bn cost-cutting scheme towards late-stage pipeline acceleration, primarily focused on oncology.

Annabel Kartal Allen

News

FDA grants fast track designation for HAYA Therapeutics’ HTX-001

Salong Debbarma

Analyst Comment

Dimerix acquisition of DMX-652 bolsters kidney disease development

GlobalData Healthcare

News

Eisai and CORE Biomedicine agree on global licence for oncology pipeline

News

Leadership changes afoot at two CGT biotechs

News

Argenx signs agreement to buy Forte Biosciences for $2.2bn

News

Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development

News

BioMarin and n-Lorem partner on early research for ReNU syndrome therapy

Analysis

Analyst Comment

FDA regenerative medicine approvals show growing momentum

GlobalData Healthcare

Comment

Why the India-UK trade deal now needs a five-gate implementation ledger

Ross Law

Features

Magazine: Made in the USA

Analyst Comment

Adult epilepsy market to reach $17.bn across 7MM by 2035

GlobalData Healthcare

Themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.

More themes

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

$3495.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

FDA grants fast track designation for HAYA Therapeutics’ HTX-001

Dimerix acquisition of DMX-652 bolsters kidney disease development

Eisai and CORE Biomedicine agree on global licence for oncology pipeline

Leadership changes afoot at two CGT biotechs

Argenx signs agreement to buy Forte Biosciences for $2.2bn

Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development

BioMarin and n-Lorem partner on early research for ReNU syndrome therapy

FDA regenerative medicine approvals show growing momentum

Why the India-UK trade deal now needs a five-gate implementation ledger

Magazine: Made in the USA

Adult epilepsy market to reach $17.bn across 7MM by 2035

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Merger and Acquisition Trends in Pharma - Q2 2026

Venture Capital Investment Trends in Pharma - Q2 2026

Emerging Market Outsourcing Report, Q2 2026

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Merger and Acquisition Trends in Pharma - Q2 2026

Venture Capital Investment Trends in Pharma - Q2 2026

Emerging Market Outsourcing Report, Q2 2026

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing